Wednesday, October 8, 2025

12:15 - 13:00

RAMÓN Y CAJAL ROOM

---

Overview

Sponsor: Euronext

---

Details

The European Healthtech and Biotech sectors are at a pivotal moment, shaped by the post-pandemic market correction, shifting investor sentiment, and evolving regulatory landscapes. This round table brings together leading voices from finance, industry, and policy to explore how capital markets can play a transformative role in strengthening Europe’s Healthtech ecosystem. Discussions will begin with an overview of the current market context, assessing the state of the sector following the pandemic-driven boom and today’s more challenging environment. The dialogue will then turn to financing pathways, comparing the roles of private equity and public markets in fueling growth, and highlighting how these sources can complement each other across different stages of company development. Participants will also examine the concept of “company readiness,” outlining the key strategic, operational, and governance elements that Healthtech companies must secure before turning to institutional investors, private equity, or IPOs. The advantages of going public in Europe will be discussed in depth, from access to larger pools of capital to enhanced visibility, credibility, and opportunities for long-term scaling. The session will close with practical advice for entrepreneurs and executives navigating this journey, offering actionable insights into how Healthtech companies can prepare, position, and thrive within Europe’s evolving capital market landscape.

---

Details